Patients: 
Who are pregnant or planning to become pregnant during the study or in the future 
With a elevated post-void residual (defined as PVR > 100cc) 
With a bleeding condition or on anti-coagulant therapy 
With immunosuppression (i.e. HIV, lymphoma) 
With multiple sclerosis or other progressive neurological disease 
With evidence of a local or systemic infection, including urinary tract infection 
With evidence of intrinsic sphincter deficiency as defined by a maximal urethral closure pressure of <20 cm H2O 
Previous sub-urethral sling 
Predominant overactive bladder symptoms       
    

NCT00676273_exc_T3
Measurement
post-void residual
NCT00676273_exc_T4
Measurement
PVR
NCT00676273_exc_T5
Value
> 100cc
NCT00676273_exc_T6
Value
elevated
NCT00676273_exc_T7
Condition
bleeding condition
NCT00676273_exc_T8
Procedure
anti-coagulant therapy
NCT00676273_exc_T9
Condition
HIV
NCT00676273_exc_T10
Condition
lymphoma
NCT00676273_exc_T11
Observation
immunosuppression
NCT00676273_exc_T12
Scope
HIV, lymphoma
NCT00676273_exc_T13
Condition
multiple sclerosis
NCT00676273_exc_T14
Condition
progressive neurological disease
NCT00676273_exc_T15
Condition
systemic infection
NCT00676273_exc_T16
Condition
urinary tract infection
NCT00676273_exc_T17
Condition
local infection
NCT00676273_exc_T18
Scope
local or systemic infection
NCT00676273_exc_T19
Condition
intrinsic sphincter deficiency
NCT00676273_exc_T20
Measurement
maximal urethral closure pressure
NCT00676273_exc_T21
Value
<20 cm H2O
NCT00676273_exc_T22
Procedure
sub-urethral sling
NCT00676273_exc_T23
Temporal
Previous
NCT00676273_exc_T24
Condition
overactive bladder symptoms
NCT00676273_exc_T26
Qualifier
Predominant
NCT00676273_exc_T2
Condition
pregnant
NCT00676273_exc_T27
Mood
planning to become
NCT00676273_exc_T28
Condition
pregnant
NCT00676273_exc_T29
Temporal
during the study
NCT00676273_exc_T30
Temporal
in the future
NCT00676273_exc_T31
Scope
during the study or in the future
NCT00676273_exc_T32
Scope
pregnant or planning to become pregnant
NCT00676273_exc_T25
Condition
overactive bladder